Hercules Capital
HTGC
16.36
-0.21
-1.27%
Hercules Capital
US · HTGC
#2460 by market cap
Listed 1970
16.36
-0.21
-1.27%
Live - 5344 symbols - heartbeat 407s ago
· 2026-10-08 05:24
Pre-market
16.40
+0.24%
After-hours
16.40
+0.24%
- Market cap
- 3.06B
- P/E (TTM)i
- 8.10
- P/Bi
- 1.35
- EPSi
- 1.85
- Div yieldi
- 11.49%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on HTGC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.3 percentage points.
Institutional ownership
- Held by institutions
- 34.52% -2.27pp
- Institutions
- 357 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund18.30%
VC/PE Fund5.10%
Hedge Fund4.76%
Public Company2.75%
Individual/Insider2.01%
Family Office/Trust1.86%
Private Company1.41%
Government Pension Fund0.33%
Other63.47%
Top holders as of 2026-04-09
Kingdom Holding Company
5.10% · 9.41M sh
Van Eck Associates Corporation
2.10% · 3.88M sh
Sound Income Strategies, LLC
1.99% · 3.67M sh
Citadel Advisors LLC
1.59% · 2.94M sh
UBS Asset Management
1.43% · 2.65M sh
Pandowealth. LLC
1.36% · 2.51M sh
Scott Bluestein
1.34% · 2.48M sh
Two Sigma Investments, LP
1.23% · 2.27M sh
LPL Financial LLC
1.01% · 1.86M sh
Morgan Stanley
0.98% · 1.80M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Scott Bluestein | CEO, Chief Investment Officer, President & Director | 1.34% |
| Seth Meyer | Chief Financial Officer | 0.24% |
| Thomas Fallon | Independent Director | 0.09% |
| Christian Follmann | Chief Operating Officer | 0.08% |
| Robert Badavas | Chairman of the Board & Lead Independent Director | 0.07% |
| Gayle Crowell | Independent Director | 0.05% |
| Kiersten Botelho | Corporate Secretary, General Counsel & Chief Compliance Officer | 0.05% |
| Wade Loo | Independent Director | 0.03% |
| DeAnne Aguirre | Independent Board Directors | 0.02% |
| Andrew Olson | Former VP of Finance, Principal Accounting Officer & Senior Controller | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-16 | Alfred Fichera | -- | Other Acquisition | +3,483 | $17.76 |
| 2026-09-16 | Alfred Fichera | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-09-08 | Seth Meyer | Chief Financial Officer | Sale to Issuer | -5 | $17.61 |
| 2026-07-08 | Scott Bluestein | CEO, Chief Investment Officer, President & Director | Sale to Issuer | -20,393 | $15.69 |
| 2026-07-08 | Christian Follmann | Chief Operating Officer | Sale to Issuer | -2,798 | $15.69 |
| 2026-07-08 | Seth Meyer | Chief Financial Officer | Sale to Issuer | -6,469 | $15.69 |
| 2026-07-08 | Kiersten Botelho | Corporate Secretary, General Counsel & Chief Compliance Officer | Sale to Issuer | -1,974 | $15.69 |
| 2026-06-17 | Robert Badavas | Chairman of the Board & Lead Independent Director | Other Acquisition | +3,873 | $15.49 |
| 2026-06-08 | Seth Meyer | Chief Financial Officer | Sale to Issuer | -5 | $15.45 |
| 2026-05-17 | Andrew Olson | Former VP of Finance, Principal Accounting Officer & Senior Controller | Initial Statement of Beneficial | 0 | -- |
| 2026-04-08 | Scott Bluestein | CEO, Chief Investment Officer, President & Director | Sale to Issuer | -20,393 | $14.74 |
| 2026-04-08 | Christian Follmann | Chief Operating Officer | Sale to Issuer | -2,798 | $14.74 |
| 2026-04-08 | Seth Meyer | Chief Financial Officer | Sale to Issuer | -6,469 | $14.74 |
| 2026-04-08 | Kiersten Botelho | Corporate Secretary, General Counsel & Chief Compliance Officer | Sale to Issuer | -1,974 | $14.74 |
| 2026-03-25 | Gayle Crowell | Independent Director | Open Market Acquisition | +7,317 | $14.35 |
| 2026-03-25 | Robert Badavas | Chairman of the Board & Lead Independent Director | Open Market Acquisition | +3,658 | $14.35 |
| 2026-03-25 | Pam Randhawa | Independent Director | Open Market Acquisition | +2,926 | $14.35 |
| 2026-03-25 | Nikos Theodosopoulos | Independent Director | Open Market Acquisition | +7,317 | $14.35 |
| 2026-03-25 | Thomas Fallon | Independent Director | Open Market Acquisition | +7,300 | $14.30 |
| 2026-03-25 | Wade Loo | Independent Director | Open Market Acquisition | +7,317 | $14.35 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:24:27 · For reference only, not investment advice and not tailored to your situation.